Charles River Laboratories Intl (CRL) 87.04

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Charles River Laboratories Intl (CRL) 87.04 $CRL

Healthcare Q2 Earnings Lineup for Aug 3: HUM, CRL & More
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:36AM CDT
The Medical sector is expected to deliver 5.4% earnings growth on 10.5% higher revenues in the second quarter.
PRXL: 66.47 (-0.94), EVHC: 23.54 (-0.05), CRL: 87.04 (-1.40), HUM: 169.57 (-1.61)

Teladoc Gaining Scale in Telehealth Market, Risk Remains
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 8:32AM CDT
Teladoc (TDOC) is witnessing its business growing steadily with insurers and customers increasingly embracing telehealth
TDOC: 17.98 (+0.44), CDNA: 4.68 (-0.12), BIOC: 0.63 (-0.13), CRL: 87.04 (-1.40)

Charles River Laboratories Schedules Second-Quarter 2016 Earnings Release and Conference Call
BusinessWire - Mon Jul 11, 3:30PM CDT
Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2016 financial results on Wednesday, August 3rd before the market opens. A conference call has been scheduled to discuss this information on Wednesday, August 3rd, at 8:30 a.m. ET.
CRL: 87.04 (-1.40)

Charles River Laboratories to Present at Jefferies and William Blair Conferences
BusinessWire - Mon Jun 06, 7:30AM CDT
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies 2016 Global Healthcare Conference in New York, New York on Wednesday, June 8th, at 10:00 a.m. EDT, and the William Blair 36th Annual Growth Stock Conference in Chicago, Illinois on Tuesday, June 14th, at 1:30 p.m. CDT (2:30 p.m. EDT). Management will present an overview of Charles River's strategic focus and business developments.
CRL: 87.04 (-1.40)

Moderna Therapeutics and Charles River Laboratories Announce Strategic Collaboration to Scale Moderna's Nonclinical Development Efforts for Novel mRNA Therapeutics
BusinessWire - Mon Jun 06, 7:00AM CDT
Moderna Therapeutics, a clinical stage pioneer in the development of messenger RNA (mRNA) Therapeutics(TM) and Charles River Laboratories International, Inc. (NYSE:CRL), a leading early-stage contract research organization (CRO), today announced a strategic collaboration to support Moderna's nonclinical discovery and development efforts. Charles River will be a key partner as Moderna continues to grow and advance its pipeline spanning multiple drug modalities and therapeutic areas, conducting nonclinical activities to progress development candidates through investigational new drug (IND)-enabling studies and into the clinic.
CRL: 87.04 (-1.40)

Charles River beats Street 1Q forecasts
Automated Insights - Wed May 04, 6:20AM CDT
WILMINGTON, Mass. (AP) _ Charles River Laboratories International Inc. (CRL) on Wednesday reported first-quarter earnings of $37.1 million.
CRL: 87.04 (-1.40)

Charles River Laboratories Announces First-Quarter 2016 Results from Continuing Operations
BusinessWire - Wed May 04, 6:00AM CDT
--- First-Quarter GAAP Earnings per Share of $0.78and Non-GAAP Earnings per Share of $0.98 -
CRL: 87.04 (-1.40)

The Zacks Analyst Blog Highlights: Emergent BioSolutions, Molina Healthcare, PAREXEL International, Air Methods and Charles River Laboratories International
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 8:30AM CDT
The Zacks Analyst Blog Highlights: Emergent BioSolutions, Molina Healthcare, PAREXEL International, Air Methods and Charles River Laboratories International
AIRM: 31.11 (-1.59), PRXL: 66.47 (-0.94), EBS: 30.47 (-0.50), CRL: 87.04 (-1.40), MOH: 57.02 (+0.86)

5 Stocks to Invest on Healthcare Rebound
Zacks Equity Research - Zacks Investment Research - Tue Apr 26, 10:42AM CDT
Healthcare stocks bounced back this month after being mostly out of favor during the first quarter.
AIRM: 31.11 (-1.59), PRXL: 66.47 (-0.94), EBS: 30.47 (-0.50), CRL: 87.04 (-1.40), MOH: 57.02 (+0.86)

Charles River Laboratories Schedules First-Quarter 2016 Earnings Release and Conference Call
BusinessWire - Thu Apr 07, 3:30PM CDT
Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2016 financial results on Wednesday, May 4th before the market opens. A conference call has been scheduled to discuss this information on Wednesday, May 4th, at 8:30 a.m. ET.
CRL: 87.04 (-1.40)

CRL November 18th Options Begin Trading
DividendChannel.com - Mon Mar 21, 10:05AM CDT
Investors in Charles River Laboratories International Inc. saw new options begin trading today, for the November 18th expiration.
CRL: 87.04 (-1.40)

Charles River Laboratories to Present at Raymond James Conference
BusinessWire - Mon Mar 07, 7:30AM CST
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Raymond James 37th Annual Institutional Investors Conference in Orlando, Florida on Tuesday, March 8th, at 10:25 a.m. ET. Management will present an overview of Charles River's strategic focus and business developments.
CRL: 87.04 (-1.40)

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2015 Results from Continuing Operations and Provides 2016 Guidance
BusinessWire - Wed Feb 10, 6:00AM CST
--- Fourth-Quarter GAAP Earnings per Share of $0.69 and Non-GAAP Earnings per Share of $1.00 -
CRL: 87.04 (-1.40)

PAREXEL International Q2 Earnings Beat, FY16 View Slashed
Zacks Equity Research - Zacks Investment Research - Thu Jan 28, 8:00AM CST
PAREXEL International Corp (PRXL) reported adjusted earnings of 90 cents per share in the second quarter of fiscal 2016, beating the Zacks Consensus Estimate by 19 cents.
PRXL: 66.47 (-0.94), INCR: 42.98 (+0.22), AHS: 42.61 (-0.70), CRL: 87.04 (-1.40)

Zacks Investment Ideas feature highlights: AMN Healthcare Services, Charles River Lab, Healthways, INC Research and Air Methods
Zacks Equity Research - Zacks Investment Research - Fri Jan 22, 8:30AM CST
Zacks Investment Ideas feature highlights: AMN Healthcare Services, Charles River Lab, Healthways, INC Research and Air Methods
AIRM: 31.11 (-1.59), INCR: 42.98 (+0.22), HWAY: 16.64 (-0.20), AHS: 42.61 (-0.70), CRL: 87.04 (-1.40)

Top Healthcare Stocks
Brian Bolan - ZACKS - Thu Jan 21, 2:17PM CST
Top Healthcare Stocks
AIRM: 31.11 (-1.59), HWAY: 16.64 (-0.20), INCR: 42.98 (+0.22), AHS: 42.61 (-0.70), CRL: 87.04 (-1.40)

Charles River Laboratories Schedules Fourth-Quarter 2015 Earnings and 2016 Guidance Release and Conference Call
BusinessWire - Wed Jan 20, 3:30PM CST
Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2015 financial results and provide 2016 guidance on Wednesday, February 10th, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, February 10th, at 8:30 a.m. ET.
CRL: 87.04 (-1.40)

New Strong Buy Stocks for January 19th
Zacks Equity Research - Zacks Investment Research - Tue Jan 19, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
CNC: 68.86 (-0.58), CBG: 28.32 (-0.25), AAL: 33.51 (-2.09), CRL: 87.04 (-1.40), CAFD: 16.67 (+0.23)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 26

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading

Top 5 Most Recently Viewed Articles

NuCana Discontinues Phase 2 Colorectal Cancer Study

Updated Category News Views 146

NuCana Provides Update on Phase 2 Randomized Colorectal Cancer Study NuTide:323 Study Discontinued Following Initial Analysis Ongoing Studies Show Promise with NUC-7738 and Pembrolizumab NuCana plc (NASDAQ: NCNA) has shared important updates about its clinical trials focused on innovative treatments for colorectal cancer. The company has made the decision to discontinue...

Continue Reading
Brøndbyernes IF Football Meeting - Key Highlights Recap

Updated Category News Views 179

Overview of the Annual General Meeting for Brøndbyernes IF Football A/S BRØNDBYERNES I.F. FODBOLD A/S CVR-nr. 83 93 34 10 This report summarizes the outcomes of the annual general meeting conducted by Brøndbyernes IF Football A/S. Key Date and Location The annual shareholders meeting took place, gathering stakeholders and shareholders at the club's headquarters. A...

Continue Reading
Uncovering the Wealth from Investing in BlackRock

Updated Category News Views 314

The Potential Growth of $1000 in BlackRock Investors often wonder how their money would grow over time if invested in strong companies. Recently, we looked into BlackRock, Inc., known by its stock ticker BLK. Over a span of 15 years, investing just $1000 into BlackRock stocks would yield an impressive value today. According to current evaluations, if you had made that...

Continue Reading
Zealand Pharma Advances Glepaglutide Approval for SBS Treatment

Updated Category News Views 267

Glepaglutide Submission to EMA Marks Significant Progress Zealand Pharma A/S, a pioneering biotechnology company, has recently shared exciting news about its Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for its innovative drug, glepaglutide. This long-acting GLP-2 analog is specifically designed for treating adults suffering from short...

Continue Reading
Seven Gables Real Estate Partners with Local Logic for Insights

Updated Category News Views 40

Seven Gables Real Estate Partners with Local Logic In a significant move that underscores their dedication to innovation, Seven Gables Real Estate has announced an exciting partnership with Local Logic, a leader in location intelligence. This collaboration is set to incorporate Local Logic's cutting-edge products—Local Content, Local Search, and NeighborhoodWrap—into...

Continue Reading